{"title":"Dopamine Hydrochloride","description":"Dopamine Hydrochloride is used as an inotropic and vasopressor agent to treat hemodynamic imbalances in conditions like cardiogenic shock, septic shock, and heart failure. It works by stimulating dopaminergic and adrenergic receptors, resulting in increased cardiac output, improved renal perfusion, and elevated blood pressure. Administered intravenously, it is a vital medication in critical care settings to stabilize cardiovascular function and support sufficient blood flow and perfusion in critically ill patients.","products":[{"product_id":"pfizer-dopamine-hydrochloride-for-injection-40-mg-ml-single-dose-vials-10-ml-10-box","title":"Dopamine Hydrochloride Injection 40 mg\/mL Single-Dose Vials 10 mL, 10\/Box by Pfizer (RX)","description":"\u003cp\u003eDopamine Hydrochloride Injection is utilized to address acute heart failure, shock, and low blood pressure. As an inotropic agent, it increases cardiac output and blood pressure by stimulating dopamine and adrenergic receptors. This injectable solution is vital in critical care settings, assisting in improving perfusion to essential organs and managing hemodynamic imbalance due to trauma, heart attack, or surgery. Its precise administration helps stabilize patients during acute medical conditions by enhancing cardiovascular function.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration and Volume:\u003c\/strong\u003e Each vial contains 40 mg\/mL of dopamine hydrochloride in a 10 mL solution, providing ample dosage for titration specific to patient needs.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e Available in boxes of 25 single-dose vials, geared towards both hospital pharmacies and emergency departments.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration Route:\u003c\/strong\u003e Designed for intravenous infusion, which is critical for ensuring immediate systemic effects.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Utilized primarily for the management of hemodynamic imbalances such as shock states—due to myocardial infarctions, cardiac surgery complications, sepsis—or in acute renal failure where enhanced renal perfusion is desired.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eDopamine functions by activating adrenergic and dopaminergic receptors in a dose-dependent manner, making it versatile for cardiovascular support:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLow Doses (0.5-2 mcg\/kg\/min):\u003c\/strong\u003e Selectively stimulates dopaminergic receptors leading to vasodilation in the renal, mesenteric, coronary, and cerebral vasculature which can improve renal perfusion and urine output.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eModerate Doses (2-10 mcg\/kg\/min): \u003c\/strong\u003ePrimarily activates beta-1 adrenergic receptors, resulting in increased cardiac output due to enhanced myocardial contractility and heart rate.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Doses (10-20 mcg\/kg\/min): \u003c\/strong\u003eEngages alpha-adrenergic receptors, causing vasoconstriction and increased systemic vascular resistance, providing a significant rise in blood pressure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular Risks: \u003c\/strong\u003eMay induce arrhythmias, tachycardia, or exacerbation of myocardial ischemia; continuous ECG monitoring is recommended.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypertensive Crisis:\u003c\/strong\u003e High doses can precipitate marked vasoconstriction and hypertension.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExtravasation Hazard:\u003c\/strong\u003e As a vasoconstrictor, extravasation can lead to severe tissue necrosis. Given this risk, administration via a central line is advised when possible, and prompt investigation should occur should extravasation be suspected.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpecific Contraindications\u003c\/strong\u003e: Patients with pheochromocytoma or uncorrected tachyarrhythmias should avoid dopamine use due to potential adverse effects.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypovolemia:\u003c\/strong\u003e Ineffectiveness in the absence of sufficient circulatory volume; imperative to correct hypovolemia prior to initiating therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiac Effects:\u003c\/strong\u003e Tachycardia, various arrhythmias.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVasculature Effects:\u003c\/strong\u003e Hypertension, vasoconstrictive complications.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRespiratory Effects:\u003c\/strong\u003e Dyspnea as a potential adverse reaction.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestive and Nervous System:\u003c\/strong\u003e Nausea, vomiting, headache, and anxiety.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eClinical Considerations:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePatient Monitoring:\u003c\/strong\u003e Intensive monitoring of vital signs, particularly blood pressure, cardiac function, and urinary output is crucial.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndividualized Dosing:\u003c\/strong\u003e Optimal outcomes rely on individualized dosing; hence, patient monitoring and titration are necessary to achieve desired therapeutic effects without adverse outcomes.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparatory Measures:\u003c\/strong\u003e Ensure all resuscitative equipment and pharmacological support are available in the care environment prior to administration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis comprehensive product should only be administered by healthcare professionals within controlled medical settings. For complete usage guidelines, always refer to the detailed prescribing information and engage healthcare providers in therapy decision-making.\u003cbr\u003e\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":39950431191112,"sku":"00409-9104-20","price":169.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Pfizer-Dopamine-Hydrochloride-for-Injection-40-mg-Single-Dose-Vials-10-mL.jpg?v=1683824278"},{"product_id":"hikma-dopamine-hydrochloride-for-injection-40-mg-ml-single-dose-vials-5-ml-25-box","title":"Dopamine Hydrochloride Injection 200 mg\/ Per 5 mL (40 mg\/mL) Single-Dose Vials 5 mL, 25\/Box (Rx)","description":"\u003cp\u003eDopamine Hydrochloride Injection 200 mg\/5 mL is used as an inotropic agent to treat various types of shock, including cardiogenic and septic shock, by improving heart function and blood flow. It stimulates dopaminergic and adrenergic receptors, increasing cardiac output, enhancing renal perfusion, and elevating blood pressure. This medication is administered intravenously in critical care settings to stabilize hemodynamics and support cardiovascular function in acutely ill patients.\u003c\/p\u003e\n\u003cp\u003eDopamine Hydrochloride Injection is a cardiovascular medication used to treat hemodynamic imbalances present in shock syndromes due to myocardial infarctions, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation. It is indicated for increased cardiac output, raised blood pressure, and improved renal flow and urine output. This formulation by Hikma Injectables comes in single-dose vials with a concentration of 200 mg per 5 mL (40 mg\/mL), packaged in boxes containing 25 vials.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e: Dopamine Hydrochloride\u003cbr\u003e\u003cstrong\u003eConcentration:\u003c\/strong\u003e 40 mg\/mL\u003cbr\u003e\u003cstrong\u003eVolume: \u003c\/strong\u003e5 mL per vial\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e 25 single-dose vials per box\u003cbr\u003e\u003cstrong\u003eUse: \u003c\/strong\u003eIV administration for the treatment of shock states\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Hikma Injectables\u003cbr\u003e\u003cstrong\u003ePurpose: \u003c\/strong\u003ePrimarily used to enhance perfusion to vital organs by improving cardiac output, blood pressure, and urine output\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDopamine serves as a sympathomimetic agent working by stimulating dopaminergic and adrenergic receptors. Its mechanism is dose-dependent:\u003c\/p\u003e\n\u003cp\u003eLow doses primarily stimulate dopaminergic receptors, promoting vasodilation and increased renal blood flow, leading to enhanced urine output.\u003cbr\u003eIntermediate doses have a predominant effect on β1-adrenergic receptors in the heart, increasing cardiac output.\u003cbr\u003eHigh doses primarily stimulate α-adrenergic receptors, leading to vasoconstriction and increased systemic vascular resistance, thus raising blood pressure.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular Effects:\u003c\/strong\u003e Continuous monitoring of cardiac rhythm, blood pressure, and urine output is essential. Avoid use in patients with pheochromocytoma or uncorrected tachyarrhythmias.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeripheral Ischemia:\u003c\/strong\u003e High doses or prolonged use can lead to vasoconstriction causing tissue ischemia, particularly in extremities.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypovolemia: \u003c\/strong\u003eCorrect any underlying hypovolemia with appropriate volume expanders before dopamine administration. Interaction with MAO Inhibitors: May potentiate the effects of dopamine; dose adjustments are needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTachycardia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePalpitations\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHeadache\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea or vomiting\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eArrhythmias or exacerbation of existing arrhythmias\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHypertension or severe hypotension\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePeripheral ischemia or gangrene from prolonged high-dose infusion\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePolyuria due to increased renal perfusion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration and Monitoring\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDopamine Hydrochloride Injection should be administered intravenously via an infusion pump for accurate control of dosing. Healthcare providers must ensure constant monitoring of vital signs, particularly heart rate and blood pressure, during infusion. Adjustments in dosing should be made based on the therapeutic response and any side effects. Close attention should be given to patients with compromised cardiovascular status and any sudden changes in rhythm should prompt reevaluation of therapy.\u003cbr\u003e\u003c\/p\u003e","brand":"Hikma Injectables","offers":[{"title":"Default Title","offer_id":39950433157192,"sku":"00143-9252-25","price":139.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Dopamine-Hydrochloride-Injection-Vial-25-Per-Box.jpg?v=1730830191"},{"product_id":"pfizer-dopamine-hydrochloride-for-injection-40-mg-ml-single-dose-vials-5-ml-25-box","title":"Dopamine Hydrochloride Injection 40 mg\/mL Single-Dose Vials 5 mL, 25\/Box by Pfizer (RX)","description":"\u003cp\u003eDopamine Hydrochloride Injection is used to treat conditions like shock or low blood pressure due to heart attack, trauma, or surgery. It functions as a vasopressor, enhancing cardiac output and improving blood flow by stimulating dopaminergic and adrenergic receptors. This medication is crucial in managing hemodynamic imbalances and supporting cardiovascular function in critical care settings, allowing for stabilization and improved perfusion to vital organs during acute medical emergencies.\u003c\/p\u003e\n\u003cp\u003eDopamine acts on adrenergic and dopaminergic receptors, offering a multi-faceted approach to cardiovascular support. At lower doses, dopamine stimulates dopaminergic receptors promoting vasodilation in renal and mesenteric vasculature, enhancing perfusion. At moderate doses, it stimulates beta-1 adrenergic receptors, increasing myocardial contractility and cardiac output. At higher doses, dopamine exhibits alpha-adrenergic activity leading to vasoconstriction, which elevates systemic vascular resistance and blood pressure. This dose-dependent receptor activity allows for tailored hemodynamic management.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration:\u003c\/strong\u003e 40 mg\/mL, providing potent dosing flexibility.\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e 25 single-dose 5 mL vials per box, ensuring availability in high-demand environments.\u003cbr\u003e\u003cstrong\u003eAdministration Route:\u003c\/strong\u003e Intravenous infusion for immediate vascular effects.\u003cbr\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e Utilized in conditions such as cardiogenic shock, acute heart failure, and renal failure, where increased cardiac output and improved renal perfusion are critical.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDopamine acts on adrenergic and dopaminergic receptors, offering a multi-faceted approach to cardiovascular support. At lower doses, dopamine stimulates dopaminergic receptors promoting vasodilation in renal and mesenteric vasculature, enhancing perfusion. At moderate doses, it stimulates beta-1 adrenergic receptors, increasing myocardial contractility and cardiac output. At higher doses, dopamine exhibits alpha-adrenergic activity leading to vasoconstriction, which elevates systemic vascular resistance and blood pressure. This dose-dependent receptor activity allows for tailored hemodynamic management.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTachycardia and Arrhythmias:\u003c\/strong\u003e Increased heart rate or arrhythmias may occur; continuous monitoring of cardiac rhythm is essential.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypertension:\u003c\/strong\u003e Over-infusion may result in excessive vasoconstriction leading to hypertension.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExtravasation Risk: \u003c\/strong\u003eDopamine is a vesicant, causing local tissue necrosis if extravasation occurs. Always use a central vein when feasible.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePheochromocytoma \u003c\/strong\u003ePatients: Contraindicated in patients with pheochromocytoma due to the risk of hypertensive crisis.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypovolemia:\u003c\/strong\u003e Ineffective if blood volume is not first corrected; ensure adequate fluid resuscitation before dopamine administration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiac Effects:\u003c\/strong\u003e Palpitations, tachycardia, ectopic heartbeats.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVascular Effects:\u003c\/strong\u003e Vasoconstriction, possible ischemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal Effects:\u003c\/strong\u003e Nausea, vomiting.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDyspnea:\u003c\/strong\u003e Respiratory difficulties may occur in some patients.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnxiety: \u003c\/strong\u003eCentral nervous system effects such as anxiety or agitation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eClinical Considerations:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing Accuracy\u003c\/strong\u003e: Due to the potent nature of the drug, precise dosing calculations and titration based on patient weight and response are crucial.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePatient Monitoring:\u003c\/strong\u003e Continuous monitoring of blood pressure, cardiac output, and urine output is necessary to gauge effectiveness and safety.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndividualized Therapy:\u003c\/strong\u003e Regular assessment and adjustment according to the clinical condition of the patient are vital in optimizing therapeutic outcomes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis product is intended for use by healthcare professionals trained in advanced critical care therapies. Always refer to the complete prescribing information for detailed usage guidelines and consult a healthcare professional before making clinical decisions.\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":39950489419848,"sku":"00409-5820-01","price":199.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Pfizer-Dopamine-Hydrochloride-for-Injection-Single-Dose-Vials-5-mL.jpg?v=1683828665"},{"product_id":"dopamine-hydrochloride-and-5-dextrose-injection","title":"IV Bags, DOPamine Hydrochloride and 5% Dextrose Injection 250 mL IV Bags, 18\/Case","description":"\u003cp\u003eDopamine Hydrochloride and 5% Dextrose Injection 250 mL IV Bags are used to increase blood pressure in patients with low blood pressure, to increase heart rate in patients with low heart rate, and to increase urine flow in patients with low urine flow. Dopamine Hydrochloride and 5% Dextrose Injection 250 mL IV Bags work by stimulating the sympathetic nervous system.\u003c\/p\u003e\n\u003cp\u003eDopamine Hydrochloride and 5% Dextrose Injection, USP is a sterile, nonpyrogenic solution of Dopamine Hydrochloride, USP and Dextrose, USP in Water for Injection.\u003c\/p\u003e\n\u003cp\u003eBrand: Baxter IV Systems\u003cbr\u003eNDC: 00338-1005-02\u003cbr\u003eUPC:303381005023\u003cbr\u003eCount: 18 bags\u003cbr\u003eSize: 250 mL\u003cbr\u003eStrength: 200 mg per 250 mL\u003c\/p\u003e","brand":"Baxter IV Systems","offers":[{"title":"Default Title","offer_id":39950634680392,"sku":"00338-1005-02","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/DOPamine-Hydrochloride-and-5_-Dextrose-Injection-250-mL-IV-Bags-00338-1005-02.jpg?v=1683893819"},{"product_id":"dopamine-hydrochloride-and-5-dextrose-injection-5000-ml-iv-bags-12-case","title":"IV Bags, Dopamine and 5% Dextrose IV Bags Injection IV infusion Dose 500 mL , 12\/Case","description":"\u003cp\u003e\u003cstrong\u003eHospital-Grade Critical Care Vasopressor \u0026amp; Inotropic Support for Shock, Hypotension, and Cardiac Emergencies\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTake rapid control of hemodynamic instability in the ICU, ER, or surgical suite with Dopamine Hydrochloride and 5% Dextrose Injection 500 mL IV Bags by Baxter IV Systems. Specially formulated for continuous intravenous infusion, this ready-to-use solution provides reliable vasopressor and inotropic support for patients in shock, acute heart failure, sepsis, hypotension, and other life-threatening, low blood pressure states. Baxter’s proven infusion bag delivery system ensures rapid availability and ease-of-use in every code cart, crash cart, and intensive care unit.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eKey Features \u0026amp; Top Clinical Benefits\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvanced Hemodynamic Management:\u003c\/strong\u003e Delivers precise titration of dopamine for restoring and maintaining adequate blood pressure, cardiac output, and organ perfusion in critically ill or unstable patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmediate Vasopressor \u0026amp; Inotropic Therapy:\u003c\/strong\u003e First-line for septic shock, cardiogenic shock, severe hypotension, and acute circulatory failure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBalanced Solution:\u003c\/strong\u003e Each 500 mL IV bag contains pre-mixed dopamine hydrochloride and 5% dextrose in water for safe, effective, and efficient administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBaxter IV Bag System:\u003c\/strong\u003e Trusted by hospitals and ICU teams worldwide for its sterile, tamper-evident, easy-to-hang design—no in-house mixing required, reduces medication errors and time to treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHospital, ICU \u0026amp; Emergency Department Essential:\u003c\/strong\u003e A must-have for clinicians managing acute shock, cardiac arrest, trauma resuscitation, perioperative blood pressure instability, and advanced cardiac life support (ACLS) protocols.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eTop Uses \u0026amp; Life-Saving Indications\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eSeptic shock (sepsis with low blood pressure)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCardiogenic shock and acute heart failure\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHypotension unresponsive to fluid resuscitation\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePost-resuscitation hemodynamic support\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePerioperative and surgical blood pressure support\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTrauma and emergency volume\/pressure restoration\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdvanced cardiac life support (ACLS) vasopressor protocols\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eWhy Choose Dopamine HCl \u0026amp; 5% Dextrose IV by Baxter?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eReady-to-use, pharmacy-grade solution—no calculations, sterile compounding, or delays\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFlexible, titratable dosing for individualized patient care\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRapid access for life-threatening emergencies\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCompatible with all hospital IV infusion pumps and standard lines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eProven clinical efficacy and industry-leading Baxter quality and compliance\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReduces medication errors and time-to-therapy compared to manual mixing\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eTop Searched Terms for Dopamine and 5% Dextrose IV Bags\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003edopamine IV infusion for shock\u003c\/li\u003e\n\u003cli\u003evasopressor for hypotension and sepsis\u003c\/li\u003e\n\u003cli\u003ehospital dopamine hydrochloride IV bag\u003c\/li\u003e\n\u003cli\u003einotropic support ICU\u003c\/li\u003e\n\u003cli\u003eBaxter dopamine and dextrose infusion\u003c\/li\u003e\n\u003cli\u003ecritical care vasopressor medication\u003c\/li\u003e\n\u003cli\u003eready-to-use dopamine IV for low blood pressure\u003c\/li\u003e\n\u003cli\u003ecardiac arrest and shock dopamine drip\u003c\/li\u003e\n\u003cli\u003eemergency dopamine HCl dextrose IV bag\u003c\/li\u003e\n\u003cli\u003ebest medication for septic shock hospital\u003c\/li\u003e\n\u003cli\u003edopamine infusion for heart failure\u003c\/li\u003e\n\u003cli\u003edopamine ACLS protocol hospital\u003c\/li\u003e\n\u003cli\u003eBaxter IV dopamine nursing\u003c\/li\u003e\n\u003cli\u003epediatric, adult dosing for dopamine infusion\u003c\/li\u003e\n\u003cli\u003eICU and ER pressor pharmacy supply\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e Intravenous infusion ONLY. For use with IV pumps and close cardiac monitoring.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults:\u003c\/strong\u003e Start at 2-5 mcg\/kg\/min, titrate for desired hemodynamic\/urine output; max dose per prescriber or protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePediatrics:\u003c\/strong\u003e Weight-based dosing per hospital guidelines.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Inspect for clarity, hang on IV pole, spike with sterile set, and program pump as directed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContinuous monitoring\u003c\/strong\u003e of ECG, blood pressure, and urine output is required during infusion.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003ePossible Side Effects\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCommon:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTachycardia (rapid heart rate)\u003c\/li\u003e\n\u003cli\u003ePalpitations\u003c\/li\u003e\n\u003cli\u003eNausea, vomiting\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious\/Seek Immediate Attention:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eVentricular arrhythmias\u003c\/li\u003e\n\u003cli\u003eChest pain or angina\u003c\/li\u003e\n\u003cli\u003eHypertensive crisis\u003c\/li\u003e\n\u003cli\u003eExtravasation\/ischemia at infusion site\u003c\/li\u003e\n\u003cli\u003eTissue necrosis (if IV infiltrates)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote\u003e\n\u003cp\u003e\u003cstrong\u003eAlways monitor IV site for infiltration; administer via central line when possible for high-dose or long-term infusions.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003ch2\u003e\u003cstrong\u003ePrecautions\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eFor use by trained medical professionals in hospital\/critical care settings only\u003c\/li\u003e\n\u003cli\u003eNot for IV bolus, SUBQ, or IM injection\u003c\/li\u003e\n\u003cli\u003eMonitor volume status to avoid fluid overload\u003c\/li\u003e\n\u003cli\u003eUse with extreme caution in patients with tachyarrhythmias, MAO inhibitor use, or peripheral vascular disease\u003c\/li\u003e\n\u003cli\u003eAdjust infusion for renal, hepatic, and pediatric patients as per hospital protocol\u003c\/li\u003e\n\u003cli\u003eNot for home or layperson use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eFor rapid, reliable vasopressor and inotropic support in the most critical cases, trust Dopamine Hydrochloride and 5% Dextrose Injection 500 mL IV Bags by Baxter IV Systems—the gold standard for hospital, ICU, and ER management of shock, hypotension, sepsis, and cardiac failure.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Baxter IV Systems","offers":[{"title":"Default Title","offer_id":39950635466824,"sku":"00338-1005-03","price":465.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Dopamine-Hydrochloride-and-5_-Dextrose-Injection-5000-mL-IV-Bags.jpg?v=1683894377"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/Dopamine_Hydrochloride.jpg?v=1730741620","url":"https:\/\/www.mountainside-medical.com\/collections\/dopamine-hydrochloride.oembed?constraint=iv-bags","provider":"Mountainside Medical","version":"1.0","type":"link"}